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Abstract
Diglycidyl ethers of bisphenol A (DGEBA) and bisphenol F (DGEBF) are widely used as
components in epoxy resin thermosetting products. They are known to cause occupational and
non-occupational allergic contact dermatitis. The aim of this study is to investigate analogues of
DGEBF with regard to contact allergy and cytotoxicity. A comprehensive knowledge of the
structural features that contribute to the allergenic and cytotoxic effects of DGEBF will guide the
development of future novel epoxy resin systems with reduced health hazards for those coming
into contact with them. It was found that the allergenic effects of DGEBF were dependent on its
terminal epoxide groups. In contrast, it was found that the cytotoxicity in monolayer cell culture
was not only dependent on the presence of epoxide groups, but also on other structural features.
Abbreviations
DGEBA

Diglycidyl ether of bisphenol A

DGEBF

Diglycidyl ether of bisphenol F

ERS

Epoxy resin systems

IARC

International Agency for Research on Cancer

LLNA

Local lymph node assay

MTT

3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide

N-ACME

N-Acetyl-L-cysteine methyl ester

PGE

Phenyl glycidyl ether

PPARγ

Peroxisome proliferator-activated receptor-gamma
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Introduction
Epoxy resin systems (ERS) are commercial thermosetting products that are combinations of
epoxy resins, curing agents, modifiers, and reactive diluents used in applications where strong,
flexible, and light-weight construction materials are required. The global epoxy resin market is
projected to reach over 3 million tons in annual sales by 2017.1 Examples of their uses are in
paints, adhesives, coatings and electrical laminates. Due to their technical advantages, ERS
continue to find new applications. Epoxy resin monomers are polymer precursor units which are
reacted with hardeners to give the polymeric material. The most commonly used epoxy resin
monomers are diglycidyl ethers based on bisphenol A (DGEBA) (also known as BADGE) and
bisphenol F (DGEBF or BFDGE) (Figure 1). Alternatives to DGEBA and DGEBF are receiving
commercial interest, as epoxy resins with a variety of properties are desired. ERS are often
modified by the addition of reactive diluents, which are used mainly to reduce the viscosity and
improve polymerization. Phenylglycidyl ether (PGE, Figure 1) is an example of a commonly
used reactive diluent.
The main concerns with use of ERS at present are their environmental impact, their cytotoxicity
and their ability to cause contact allergy. Epoxy resin monomers are among the most common
causative agents of occupational contact dermatitis.2 Skin sensitization is known to be
particularly common amongst construction workers and is caused by ERS present in cement and
other building materials,3, 4 but is also frequent in newer settings such as the production of wind
turbine rotor blades5 and epoxy pipe relining.6 Epoxy resin monomers are also implicated in nonoccupational contact allergy.7, 8 DGEBA is included in the European baseline series for diagnosis
of contact allergy.9 ERS components other than the resin monomers have also been shown to be
potent sensitizers.10 Allergic contact dermatitis from various epoxy resin system components6, 113
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including DGEBA and DGEBF5, 19 has been reported. The skin sensitization potential has been

investigated experimentally in vivo in mice and guinea pigs for DGEBA,20,
PGE23,

24

21

DGEBF,21,

22

and others.25 DGEBA, DGEBF and PGE are strong sensitizers in both species

according to regulatory classifications.26
A number of ERS components have been demonstrated to be cytotoxic. PGE and resorcinol
diglycidyl ether are classified by IARC as possibly carcinogenic to humans (class 2B).27 PGE is
known to bind to and damage DNA in vitro.28 DNA damage, with sufficient dose and length of
exposure, will trigger apoptosis and cytotoxicity.29 The genotoxicity of epoxides including PGE
is known30 and PGE was suggested to be a direct-acting mutagen as long ago as 1979.31 A
previous study of a series of six epoxides noted that diepoxide functionality and aromaticity
increased the induction of apoptosis and cytotoxicity.29 It has been shown that DGEBA alkylates
the isolated nucleophiles 4-(p-nitrobenzyl)-pyridine and deoxyguanosine.32 DGEBF is cytotoxic
in the hepatoma cell line HepG233 and in intestinal Caco-2 cells.34 DGEBA was shown to be an
antagonist of the nuclear transcription factor peroxisome proliferator-activated receptor-gamma
(PPARγ) in 3T3-L1 and 3T3-F442A preadipocytes.35 PPARγ inhibitors cause apoptosis and cell
cycle arrest in colorectal carcinoma cells.36 In contrast, DGEBA acted as a PPARγ agonist in an
ECV403 cell line.37 Further research demonstrated that DGEBA can also induce apoptosis
independently of PPARγ in both caspase-dependent and independent manners.38, 39
In this work we sought to investigate which structural features of DGEBF are important for its
skin sensitizing potency. The in vivo murine local lymph node assay (LLNA)40 and the in vitro
KeratinoSens™ assay41 were used to determine the sensitizing effects of the compounds. We
also assessed the in vitro cytotoxicity of DGEBF analogues in the KeratinoSens™ cell line. The

4

chemical reactivity was investigated using a model peptide and a model amino acid to estimate
the possibility of binding to reactive residues in skin proteins.
Experimental Procedures
Caution: This study involves skin sensitizing compounds which must be handled with care.

Instrumentation and Mode of Analysis. 1H and
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C NMR spectroscopy was performed on a

Jeol Eclipse 400 spectrometer at 400 and 100 MHz, respectively, using CDCl3 solutions (residual
CHCl3 δ 7.26 and CHCl3 δ 77.0 as internal standards). Electron-ionization mass spectral analysis
(70 eV) was performed on a Hewlett-Packard 5973 mass spectrometer connected to a gas
chromatograph (Hewlett-Packard 6890). The GC was equipped with a cool on-column capillary
inlet and an HP-5MSi fused silica capillary column (30 m × 0.25 mm, 0.25 µm, Agilent
Technologies, Palo Alto, CA). Helium was used as carrier gas, and the flow rate was 1.2
mL/min. The temperature program started at 70 °C for 1 min, increased by 10 °C/min, and ended
at 270 °C for 5 min. For mass spectral analysis, the mass spectrometer was used in the scan
mode detecting ions with m/z values ranging from 50 to 1500.

High performance liquid chromatography/mass spectrometry (LC/MS) analyses were performed
using electrospray ionization (EIS) on a Hewlett-Packard 1100 HPLC/MS. The system included
a vacuum degasser, a binary pump, an autoinjector, a column thermostat, a diode array detector,
and a single quadrupole mass spectrometer. The HPLC was equipped with a HyPURITY C18
column (150 × 3 mm i. d., particle size 3 µm, Thermo Hypersil-Keystone, Thermo Electron
Corp., Bellafonte, PA). The mobile phase consisted of 0.005% pentafluoropropanoic acid, 0.1%
acetic acid, and 5% acetonitrile in water (solvent A) and 0.005% pentafluoropropanoic acid,
5

0.1% acetic acid, and 50% water in acetonitrile (solvent B). A linear gradient from 0% to 100%
B in 20 min, followed by 10 min of isocratic elution was used. The flow rate was 0.40 mL/min
and the column temperature was set to 40 °C. The electrospray interface was used with the
following spray chamber settings: nebulizer pressure, 40 psig; capillary voltage, 3500 V; drying
gas temperature, 350 °C; and drying gas flow rate, 10 L/min. Fragmentor voltage was set to 120
V. The mass spectrometer was used in scan mode detecting molecular ions with m/z values
ranging from 50 to 2000.

DGEBA, DGEBF, PGE and 3 (Figure 1) were purchased from Sigma-Aldrich; DGEBF was
obtained as a mixture of three isomers. Resorcinol diglycidyl ether (3) was 91% pure when
purchased and was further purified by column chromatography (hexane: ethyl acetate 7:3) prior
to evaluation. Acetone was purchased from Merck (Darmstadt, Germany) and olive oil from
Apoteket AB (Goteborg, Sweden). The peptide AcPHCKRM was purchased from Peptide 2.0
Inc. (Chantilly, USA). Unless otherwise indicated, reagents were obtained from commercial
suppliers and used without further purification. TLC was performed using silica gel coated
aluminium plates. The purity of both synthesized and purchased test compounds was >98%
(GC/MS) before evaluation in biochemical and biological assays.

Chemical Synthesis

2-((4-(4-(2-Methoxyethoxy)benzyl)phenoxy)methyl)oxirane (1) (Scheme 1A).
4-(2-Methoxyethoxy)benzoic acid (7): A solution of KOH (9.40 g, 166 mmol) in anhydrous
ethanol (85 mL) was added to a solution of 4-hydroxybenzoic acid (10.0 g, 72.4 mmol) in
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anhydrous ethanol (115 mL) under nitrogen atmosphere. The white suspension was stirred with
dropwise addition of 2-bromo-1-methoxyethane (8.84 mL, 13.0 g, 94.1 mmol). The reaction
mixture was refluxed for 24 h under nitrogen atmosphere. A solution of KOH (8.25 g, 63.5
mmol) in anhydrous ethanol (75 mL) was added and the reaction mixture was refluxed for a
further 2 h. After evaporation of the solvent, the residue was dissolved in water (500 mL) and
acidified to pH=1 with diluted HCl (1 N). The precipitate was isolated by filtration, dried and
purified by recrystallization in ethanol, to give 7 (12.14 g, 86%) as white crystals. 1H NMR δ
3.46 (3H, s), 3.78 (2H, t, J=9.26 Hz), 4.19 (2H, t, J=9.52 Hz), 6.97 (2H, d, J=8.79 Hz) 8.05 (2H,
d, J=8.79 Hz). 13C NMR δ 59.3, 67.4, 70.7, 114.3, 121.8, 132.3, 163.2, 171.3. ESI-MS (70 eV),
m/z (%) 196 (66) (M+), 179 (2), 164 (1), 151 (6), 138 (13), 121 (33), 105 (6), 93 (5), 76 (6), 59
(100).

N-Methoxy-4-(2-methoxyethoxy)-N-methylbenzamide (8): N-Methylmorpholine (2.8 mL,
2.49 g, 25.4 mmol) was added dropwise to a solution of 7 (4.64 g, 23.7 mmol) in freshly distilled
THF (35 mL) under nitrogen atmosphere. Isopropyl chloroformate (27.8 mL, 26 mmol) was
added dropwise at -20 ºC and the reaction mixture was stirred for 30 min at -20 ºC. Freshly
distilled triethylamine (5.2 mL, 37.3 mmol) was added to a suspension of N,Odimethylhydroxylamine hydrochloride (3.63 g, 37.6 mmol), in anhydrous DMF (20 mL). The
suspension was added to the reaction mixture at 0 ºC. After 3.5 hours at 0 ºC, the reaction
mixture was quenched with water (300 mL). The aqueous phase was extracted with ethyl acetate
(3 × 100 mL). The combined organic layers were washed with HCl (1 N) (125 mL), saturated
aqueous NaHCO3 (125 mL) and brine (125 mL) and were dried over anhydrous Na2SO4, filtered
and concentrated in vacuo. The yellow oil was purified by column chromatography (CH3OH:
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CH2Cl2, 0.5: 99.5) (Rf = 0.32), to give 8 (3.22 g, 57%) as a colorless oil. 1H NMR δ 3.35 (3H, s),
3.46 (3H, s), 3.55 (3H, s), 3.74-3.80 (2H, m), 4.13-4.18 (2H, m), 6.93 (2H, d, J=8.79 Hz), 7.71
(2H, d, J=8.79 Hz).

C NMR δ 33.9, 59.2, 60.8, 67.3, 70.8, 113.8, 126.2, 130.5, 160.7, 169.3.
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ESI-MS (70 eV), m/z (%) 239 (2) (M+), 209 (1), 179 (100), 135 (4), 121 (82), 104 (7), 93 (9), 76
(6), 59 (20).

(4-tert-Butyldimethylsilyloxyphenyl)(4-(2-methoxyethoxy)phenyl)methanone (9): A solution
of (4-bromophenoxy)-tert-butyldimethylsilane (97%) (5.02 mL, 5.92 g, 20 mmol) in freshly
distilled THF (20.0 mL) under nitrogen atmosphere was stirred for 5 min and then cooled to -78
°C. After stirring for a further 10 min, N-butyllithium (2.5 M in hexanes) (8.4 mL, 22 mmol, 2
equiv) was added dropwise to the solution. The temperature was kept at -78 °C for 20 min, and
then kept at -40 °C for 40 min. A solution of 8 (2.39 g, 10 mmol) in freshly distilled THF (15
mL) was added dropwise to the in situ generated aryllithium under nitrogen atmosphere at -78
°C. The temperature was kept at -78 °C for 1 h, then kept at -30 °C for 40 min and then kept at
room temperature for 1.5 h. Aqueous HCl (1 N) (13 mL) was added and after 30 min, the
biphasic mixture was partitioned between chloroform (30 mL) and water (50 mL). The organic
phase was washed with saturated, aqueous NaHCO3 (3 × 100 mL). The combined organic layers
were dried with anhydrous Na2SO4 and concentrated in vacuo. The yellow oil was purified by
column chromatography (hexane: ethyl acetate, 5:1) (Rf = 0.22), to give 9 (3.66 g, 95%) as a
colorless oil. 1H NMR δ 0.25 (6H, s), 1.00 (9H, s), 3.47 (3H, s), 3.77-3.81 (2H, m), 4.18-4.22
(2H, m), 6.89 (2H, d, J=8.79 Hz), 6.98 (2H, d, J=8.79 Hz), 7.72 (2H, d, J=8.79 Hz), 7.78 (2H, d,
J=8.79 Hz).

C NMR δ -4.4, 18.2, 25.6, 59.3, 67.4, 70.8, 114.0, 119.6, 130.9, 131.3, 132.1,
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132.2, 159.5, 162.0, 194.6. ESI-MS (70 eV), m/z (%) 386 (100) (M+), 329 (99), 270 (21), 209
(91), 179 (68), 121 (69).

1-tert-Butyldimethylsilyloxy-4-(4-(2-methoxyethoxy)benzyl)benzene (10): Solid zinc iodide
(3.89 g, 12.2 mmol) and sodium cyanoborohydride (3.82 g, 60.9 mmol) were added to a solution
of 9 (3.14 g, 8.12 mmol) in 1,2-dichloroethane (40 mL) at room temperature. After 20 h, the
reaction mixture was filtered through Celite and the Celite was washed with CH2Cl2 The filtrate
was concentrated in vacuo, to give 10 (3.01 g, 98%) as a colorless oil. 1H NMR δ 0.17 (6H, s),
0.97 (9H, s), 3.45 (3H, s), 3.72-3.77 (2H, m), 3.85 (2H, s), 4.08-4.12 (2H, m), 6.74 (2H, d,
J=8.42 Hz), 6.85 (2H, d, J=8.42 Hz), 7.00 (2H, d, J=8.42 Hz), 7.07 (2H, d, J=8.42 Hz). 13C NMR
δ -4.5, 18.2, 25.7, 40.2, 59.2, 67.2, 71.0, 114.5, 119.9, 129.6, 129.7, 133.9, 134.2, 153.8, 157.0.
ESI-MS (70 eV), m/z (%) 372 (87) (M+), 316 (19), 287 (6), 256 (13), 195 (100), 165 (18), 150
(8), 133 (29), 107 (19), 89 (25), 73 (6), 59 (14).

4-(4-(2-Methoxyethoxy)benzyl)phenol (11): A solution of tetra-n-butylammonium fluoride in
THF (1 M) (8.5 mL, 8.5 mmol) was added to a solution of 10 (3.0 g, 8.08 mmol) in freshly
distilled THF (33 mL) under nitrogen atmosphere. After 3 h at room temperature, the reaction
mixture was diluted with ethyl acetate (75 mL) and washed with a saturated solution of NH4Cl
(140 mL). The aqueous layer was extracted with ethyl acetate (3 × 75 mL). The combined
organic layers were washed with water (2 × 175 mL), brine (175 mL), dried over anhydrous
Na2SO4 and concentrated in vacuo. The white crystals were purified by column chromatography
(CH3OH: toluene, 6:94) (Rf = 0.55), to give 11 (1.87 g, 90%) as white crystals. 1H NMR δ 3.45
(3H, s), 3.75 (2H, t, J=9.52 Hz), 3.84 (2H, s), 4.10 (2H, t, J=9.52 Hz), 6.74 (2H, d, J=8.06 Hz),
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6.84 (2H, d, J=8.42 Hz), 7.02 (2H, d, J=8.42 Hz), 7.06 (2H, d, J=8.42 Hz).
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C NMR δ 40.1,

59.2, 67.2, 71.1, 114.6, 115.2, 129.7, 129.9, 133.7, 133.9, 153.8, 157.0. ESI-MS (70 eV), m/z (%)
258 (100) (M+), 199 (40), 183 (16), 165 (9), 152 (11), 107 (51), 94 (6), 77 (6), 59 (47).

2-((4-(4-(2-Methoxyethoxy)benzyl)phenoxy)methyl)oxirane (1): Epichlorohydrin (1.14 mL,
14.4 mmol) was added dropwise to a reaction mixture of 11 (0.92 g, 3.74 mmol) and Cs2CO3
(2.34 g, 7.12 mmol) in freshly distilled acetonitrile (60 mL). The reaction mixture was refluxed
for 3 h under nitrogen atmosphere. Water (100 mL) and ethyl acetate (50 mL) were added at
room temperature and the separated water phase was extracted with ethyl acetate (3 × 60 mL).
The combined organic layers were washed with brine (200 mL), water (200 mL) and brine (200
mL), dried over anhydrous Na2SO4 and concentrated in vacuo. The mixture was purified by
column chromatography (CH3OH: CH2Cl2, 1:99) (Rf = 0.47) to give 1 (0.91 g, 78%) as white
crystals. 1H NMR δ 2.4 (1H, dd, J=4.76, 2.56 Hz), 2.89 (1H, t, J=8.79 Hz), 3.31-3.37 (1H, m),
3.44 (3H, s), 3.71-3.76 (2H, m), 3.86 (2H, s), 3.90-3.97 (1H, m), 4.06-4.12 (3H, m), 4.15-4.21
(1H, m), 6.81-6.88 (4H, m), 7.04-7.11 (4H, m).

C NMR δ 40.1, 44.7, 50.1, 59.2, 67.2, 68.8,
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71.0, 114.6, 129.7, 129.8, 133.8, 134.3, 156.8, 157.1. LC/MS (API-ES, 120 V) m/z (%): 337.1
[M+Na] (40), 332.1 [M+H2O] (100), 315.1 [M+H] (3), 165.1 (58), 163.1 (51.5), 107.1 (9), 59.1
(8.3).

Bis(4-(2-methoxyethoxy)phenyl)methane (2) (Scheme 1B). A solution of potassium hydroxide
(0.74 g, 13.2 mmol) in anhydrous ethanol (ca 10 mL) was added to a solution of 4,4'methylenediphenol (1.10 g, 5.5 mmol) in anhydrous ethanol. 2-Bromo-1-methoxyethane (1.34
mL, 14.3 mmol) was added and the reaction was refluxed for 4 h. The solvent was evaporated
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and the residue was diluted with ethyl acetate (70 mL) and washed successively with HCl (1 M,
50 mL), NaOH (2 M, 50 mL) and water (50 mL), and then dried over Na2SO4. The solvent was
evaporated in vacuo. The product was purified by column chromatography (CH3OH: CH2Cl2,
0:100, then 0.25:99.75 then 0.5:99.5) to give pure 2 (0.50 g, 29%). 1H NMR δ 3.43 (6H, s), 3.713.74 (4H, m), 3.85 (2H, s), 4.07-4.09 (4H, m), 6.83 (4H, d, J=6.6 Hz), 7.96 (4H, d, J=8.8 Hz).
C NMR δ 40.2, 59.3, 67.3, 71.2, 114.6, 123.8, 134.0, 157.2. ESI-MS (70 eV) m/z (%) 316 (100)
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(M+), 257 (18), 207 (34), 199 (19), 107 (19), 59 (66).

(2-Methoxyethoxy)benzene (4) (Scheme 1C). A solution of KOH (12 mmol) in dry ethanol (5
mL) was added to phenol (0.49 g, 5.3 mmol) in dry ethanol (5 mL). 2-Bromo-1-methoxyethane
(0.65 mL, 6.9 mmol) was added and the reaction was refluxed for 4 h. The solvent was
evaporated and the residue was dissolved in ethyl acetate (70 mL). The organic layer was washed
successively with HCl (1M, 50 mL), NaOH (2 M, 50 mL) and water (50 mL) and was dried over
Na2SO4. The solvent was evaporated in vacuo. The product was purified by column
chromatography (hexane: ethyl acetate 9:1) to yield 4 (0.22 g, 27%). 1H NMR δ 3.45 (3H, s),
3.73 - 3.76 (2H, m), 4.11-4.13 (2H, m), 6.93-6.95 (3H, m), 7.26-7.30 (2H, m). 13C NMR δ 59.3,
67.2, 71.1, 114.7, 120.9, 129.5, 158.8. ESI-MS (70eV) m/z (%) 152 (61) (M+), 107 (11), 94 (55),
77 (51), 65 (17), 59 (100), 51 (17).

1,5-Bis(2,3-epoxypropoxy)pentane (5) (Scheme 2).
1,5-Bis(allyloxy)pentane (12): Sodium hydride (0.62 g, 26 mmol, 5.2 equiv) was washed with
hexane (20 mL × 2), suspended in anhydrous THF (40 mL) and cooled to 0 ⁰C. Pentane-1,5-diol
(0.52 g, 5.0 mmol) was dissolved in anhydrous THF (20 mL) and added to the suspension. The
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mixture was stirred at 0 ⁰C for 10 min. Allyl bromide (1.12 mL, 13 mmol, 2.6 equiv) was added
and the mixture was stirred at room temperature for 90 min before refluxing overnight. The
reaction was continued until TLC indicated disappearance of the starting material. The mixture
was cooled to 0 ⁰C and saturated aqueous NH4Cl (70 mL) was added slowly to quench the
reaction. The aqueous layer was extracted with ethyl acetate (70 mL × 3). The combined organic
fractions were washed with brine (150 mL), dried over anhydrous Na2SO4 and reduced in vacuo.
Compound 12 was obtained as a colorless oil (0.70 g, 76%). 1H NMR δ 1.35-1.41 (m, 2H), 1.531.59 (m, 4H), 3.36 (t, 4H, J=6.6 Hz), 3.90-3.91 (m, 4H), 5.09-5.12 (m, 2H), 5.18-5.25 (m, 2H),
5.81-5.90 (m, 2H).

13

C NMR δ 22.9 (CH2), 29.6 (CH2), 70.3 (CH2), 71.8 (CH2), 116.7 (CH2),

135.1 (CH). EI-MS (70 eV), m/z (%) 143 (12), 127 (13), 97 (7), 85 (100), 69 (47), 57 (26).

1,5-Bis(2,3-epoxypropoxy)pentane (5): A solution of 12 (0.7 g, 3.8 mmol) in chloroform (20
mL) was cooled to 0 ⁰C. 3-Chloroperbenzoic acid (≤77%, 1.96 g, 11.4 mmol) was added and the
mixture was stirred at 0 ⁰C for 2 h. The mixture was then stirred at room temperature with
further additions of 3-chloroperbenzoic acid until the reaction was complete according to TLC.
Aqueous NaOH (40 mL) (10% w/v) was added and the aqueous phase was extracted with
CH2Cl2 (40 mL). The organic phase was washed with brine (40 mL), dried over anhydrous
Na2SO4 and reduced in vacuo. Compound 5 was isolated as a colorless oil (0.50 g, 61%) after
column chromatography (hexane: ethyl acetate, 8:2). 1H NMR δ 1.35-1.39 (m, 2H), 1.52-1.60
(m, 4H), 2.54-2.56 (m, 2H), 2.73-2.75 (m, 2H), 3.07-3.11 (m, 2H), 3.29-3.33 (m, 2H), 3.39-3.49
(m, 4H), 3.67 (dd, 2H, J=2.96, 11.72 Hz).

13

C NMR δ 22.7, 29.5, 44.3, 50.9, 71.5. EI-MS (70

eV), m/z (%) 143 (4), 113 (24), 100 (5), 85 (82), 69 (78), 57 (100).

12

1,7-Bis(2,3-Epoxypropoxy)heptane (6) (Scheme 2).
1,7-Bis(allyloxy)heptane (13): Sodium hydride (0.62 g, 26 mmol, 5.2 equiv) was washed with
hexane (2 × 20 mL), suspended in anhydrous THF (40 mL) and cooled to 0 ⁰C. Heptane-1,7-diol
(0.66 g, 5.0 mmol) was dissolved in anhydrous THF (20 mL) and added to the suspension. The
mixture was stirred at 0 ⁰C for 10 min. Allyl bromide (1.56 g, 13 mmol, 2.6 equiv) was added
and the mixture was stirred at room temperature for 90 min before refluxing overnight. The
reaction was continued until TLC indicated disappearance of the starting material. The mixture
was cooled to 0 ⁰C and saturated aqueous NH4Cl (70 mL) was added slowly to quench the
reaction. The aqueous layer was extracted with ethyl acetate (3 × 70 mL). The combined organic
fractions were washed with brine (150 mL), dried over anhydrous Na2SO4 and reduced in vacuo.
Compound 13 was obtained as a colorless oil (0.81 g, 76%). 1H NMR δ 1.24-1.36 (m, 6H), 1.511.57 (m, 4H), 3.38 (t, 4H, J=6.6 Hz), 3.91-3.93 (m, 4H), 5.11-5.14 (m, 2H), 5.21-5.26 (m, 2H),
5.83-5.92 (m, 2H).
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C NMR δ 26.2, 29.4, 29.8, 70.5, 71.9, 116.8, 135.1. EI-MS (70 eV), m/z

(%) 171 (19), 125 (5), 113 (21), 97 (65), 81 (17), 71 (42), 55 (100).

1,7-Bis(2,3-epoxypropoxy)heptane (6): A solution of 13 (0.8 g, 3.8 mmol) in chloroform (20
mL) was cooled to 0 ⁰C. 3-Chloroperbenzoic acid (≤77%, 1.96 g, 11.4 mmol) was added and the
mixture was stirred at 0 ⁰C for 2 h. The mixture was then stirred at room temperature with
further additions of 3-chloroperbenzoic acid until the reaction was complete according to TLC.
Aqueous NaOH (40 mL) (10% w/v) was added and the aqueous phase was extracted with
CH2Cl2 (40 mL). The organic phase was washed with brine (40 mL), dried over anhydrous
Na2SO4 and reduced in vacuo. Purification by column chromatography (hexane: ethyl acetate,
8:2) gave 6 as a colorless oil (0.54 g, 58%). 1H NMR δ 1.29-1.32 (m, 6H), 1.51-1.55 (m, 4H),
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2.55-2.57 (m, 2H), 2.74-2.76 (m, 2H), 3.07-3.11 (m, 2H), 3.30-3.35 (m, 2H), 3.38-3.48 (m, 4H),
3.64-3.68 (m, 2H). 13C NMR δ 26.1, 29.3, 29.7, 44.4, 50.9, 71.5, 71.7. EI-MS (70 eV), m/z (%)
141 (1), 127 (3), 113 (12), 95 (74), 87 (10), 81 (16), 75 (12), 69 (48), 55 (100).

Experimental Animals. Female CBA/Ca mice, 8 or 9 weeks of age, were purchased from
NOVA SCB Charles River, Germany. The mice were housed in “hepa” filtered air flow cages
and kept on standard laboratory diet and water ad lib. The local ethics committee in Gothenburg
approved the study.

Skin Sensitization Potency of Epoxy Resins in Mice. The local lymph node assay (LLNA)40
was used to assess the sensitization potency. Mice in six groups of three animals in each were
treated by topical application on the dorsum of both ears with the test compound (25 µL)
dissolved in acetone:olive oil (AOO) (4:1 v/v) or with the vehicle control. All solutions were
freshly prepared for each application. Each compound was tested at five different concentrations.
The test concentrations used were as follows: 1 and 2: 1, 5, 10, 20 and 30% (w/v); Treatments
were performed daily for three consecutive days (days 0, 1, and 2). Sham treated control animals
received vehicle alone. On day 5, all mice were injected intravenously via the tail vein with
[methyl-3H]thymidine (2.0 Ci/mmol, Amersham Biosciences, UK) (20 µCi) in phosphatebuffered saline (PBS, containing 137 mM NaCl, 2.7 mM KCl and 10 mM phosphate buffer, pH
7.4) (250 µL). After 5 h the mice were sacrificed, the draining lymph nodes were excised and
pooled for each group, and single cell suspensions of lymph-node cells in PBS were prepared
using cell strainers (Falcon, BD labware, 70 µm pore size). Cell suspensions were washed twice
with PBS, precipitated with TCA (5%) and left in the refrigerator overnight. The samples were
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then centrifuged, resuspended in TCA (5%) (1 mL) and transferred to a scintillation cocktail (10
mL) (EcoLume, INC Radiochemicals, USA). The [methyl-3H]thymidine incorporation into DNA
was measured by β-scintillation counting on Beckman LS 6000TA Instruments. Results are
expressed as mean dpm/lymph node for each experimental group and as stimulation index (SI),
i.e., test group/control group ratio. Test materials that at one or more concentrations caused an SI
greater than 3 were considered to be positive in the LLNA. EC3 values (the estimated
concentration required to induce an SI of 3) were calculated by linear interpolation. The
sensitization potency was classified to the following: ≤0.2% w/v, extreme; >0.2 to ≤2% w/v,
strong; >2% w/v moderate.26
KeratinoSens™ Assay for Sensitization and Cellular Viability. The KeratinoSens™ assay
was performed as previously described in detail.41, 42 Briefly, cells were grown for 24 h in 96well plates. The medium was then replaced with medium containing the test chemical and a final
level of 1% DMSO. Each compound was tested at 12 binary dilutions in the range from 0.98 to
2000 µM. Each test plate contained seven test chemicals, six wells with the solvent control, one
well with no cells for background value and five wells with the positive control cinnamic
aldehyde in five different concentrations. In each repetition, three parallel replicate plates were
run with this same set-up and a fourth parallel plate was prepared for cytotoxicity determination.
Cells were incubated for 48 h with the test agents, after which luciferase activity and cytotoxicity
(with the MTT assay43) were determined. This full procedure was repeated three times for each
chemical.
Thiol Reactivity with N-Acetyl Cysteine Methyl Ester. Compound DGEBF or 2 (1 mmol) was
stirred with N-ACME (1 mmol) at 37 °C overnight in a 2:1 solution of DMSO: ammonium
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acetate buffer (100 mM pH 7.4). The reaction was analyzed using LC/MS (see parameters
above).
Reactivity with the Model Peptide Ac-Pro-His-Cys-Lys-Arg-Met-OH (AcPHCKRM). All
solvents were degassed with argon prior to use. The hexapeptide AcPHCKRM (Peptide 2.0) was
>99% pure as determined by HPLC (UV220nm). Bz-His-OMe (Bachem) was used as an internal
standard. Solutions of PGE, DGEBF or compound 1 in DMSO (40 mM, 100 µL) together with
potassium phosphate buffer (100 mM, pH 7.4), (200 µL) were added to a vial purged with argon
containing AcPHCKRM in DMSO (4 mM, 100 µL). Accordingly, final concentrations of
compound and model peptide in the reaction mixture were 10 mM and 1 mM, respectively. The
reaction mixture was kept under argon at room temperature and was monitored with
UV210nm/ESI-MS. As the HPLC run time was 40 minutes, data was combined from two
experiments. In the first experiment, samples were collected at t=0, 40, 80, 120 mins and in the
second experiment at t=20, 60, 100 mins. In a modified experiment using two haptens
simultaneously, 50 μL of both PGE and DGEBF (50 mM) were added to the solution containing
the peptide, with the other experimental details remaining as above.
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Results and Discussion
Chemical Synthesis
Efficient synthetic strategies were employed to produce the biaromatic compounds 1 and 2
illustrated in Figure 1. A six-step synthesis was used to obtain the non-symmetrical compound 1
(Scheme 1, A). 2-Bromoethyl methyl ether and 4-hydroxybenzoic acid were reacted (step i) and
the isolated product 7 was subsequently reacted with N,O-dimethylhydroxylamine hydrochloride
to produce the Weinreb amide 8 (step ii). The amide 8 was then coupled to 1-bromo-4-tertbutyldimethylsilyloxybenzene to yield the biaromatic product 9 (step iii). After reduction (step
iv) and deprotection (step v), the final product 1 was obtained by alkylation of the free phenolic
group with epichlorohydrin in 32% overall yield (step vi).
Synthesis of 2 was achieved in a one-step reaction in a moderate yield of 29% (Scheme 1, B).
The monoalkylated compound was isolated as a by-product. Synthesis of 4 was achieved from
phenol in 27% yield (Scheme 1, C). Both 1 and 2 were synthesized as tools to investigate the
effects of the epoxide functionalities of DGEBF and cannot be used as epoxy resin monomer
replacements for polymer synthesis. Compound 1, with one terminal epoxide group and one
terminal methoxy group, can only form dimers and compound 2, with two terminal methoxy
groups, cannot react with itself or other epoxide-containing polymeric precursors.
Linear compounds 5 and 6 were synthesized to investigate the influence of sterical shape on the
cytotoxicity of 2. A 5-carbon chain was chosen as it most closely imitates the inter-atomic
distance between the two epoxide groups of DGEBF (14.47 Å for 5 compared to 14.75 Å for
DGEBF) (Table S1, Supporting Information). The compound with a 7-carbon chain, 6, was also
synthesized to obtain supplemental information. These linear epoxides have greater flexibility
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than DGEBF and hence there are a large number of conformations possible. Compounds 5 and 6
were obtained in two steps from 1,5-pentanediol and 1,7-heptanediol, respectively (Scheme 2).
The diallylic intermediates 12 and 13 were each obtained in 76% yield by refluxing the starting
material with allyl bromide and sodium hydride in an inert atmosphere (step i). The final
compounds are formed by epoxidation using meta-chloroperbenzoic acid (mCPBA) (step ii). The
corresponding monoepoxides were observed as by-products.
Skin Sensitization Potency Studies: LLNA and KeratinoSens™
Biaromatic compounds 1 and 2 were assessed in vivo for skin sensitization potency using the
murine local lymph node assay (LLNA).44 LLNA results are expressed as EC3 values, which is
the estimated concentration of a substance required to induce a 3-fold increase in sensitization
compared to a control.
The EC3 value obtained for compound 1 was 74 mM (2.3% w/v) (Figure 2 and Table S2,
Supporting Information). The stimulation index decreases for the 20% and 30% concentrations
compared to that of 10%. This effect was seen in repeated LLNA experiments with 1. Previously
reported LLNA EC3 values for DGEBA, DGEBF and PGE indicate that they are equipotent at
36 mM, 36 mM and 31 mM (1.2, 1.1 and 0.46% w/v), respectively.21, 23 According to suggested
regulatory classifications, all three are sensitizers of strong potency.26 The monoepoxide 1 has
reduced sensitization potency in the LLNA compared to DGEBF and is classified as a moderate
sensitizer according to its EC3 value of 2.3% w/v. Compound 2 does not contain any reactive
epoxide groups and was non-sensitizing in concentrations up to 30% w/v (950 mM) (Figure 2).
This compound did not show any dose-response relationship at the concentrations tested. The
only structural difference between compound 2 and DGEBF is lack of epoxide groups in
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compound 2 (Figure 1). Thus, our results show that epoxide groups are directly responsible for
the skin sensitization effects of DGEBF in the LLNA.
To obtain further information, all compounds were evaluated in the in vitro KeratinoSens™
assay.42 In this assay, compounds are rated as skin sensitizers if they induce the luciferase gene
by greater than 1.5-fold at non-cytotoxic concentrations. Previously published values predict
DGEBA, DGEBF and PGE to be sensitizers, giving a 1.5-fold induction at low micromolar
concentrations.21 The KeratinoSens™ assay predicts 1 as a sensitizer (Table 1). Partial
cytotoxicity of a chemical may lead to a luciferase induction in dying cells and therefore
chemicals are rated as sensitizers only when luciferase induction starts at non-cytotoxic
concentrations.42 For compound 2, >1.5-fold induction can only be noted at cytotoxic
concentrations, and thus 2 is classified as a non-sensitizer by this method. The KeratinoSens™
results for both biaromatic compounds are in agreement with the LLNA data.
Linear diepoxides 5 and 6 were predicted to be sensitizers by the KeratinoSens™, with
maximum induction values (Imax) of 209 and 43, respectively. These compounds were not
evaluated in the LLNA due to ethical considerations, but it is not surprising that they are
predicted to be sensitizers as both contain two terminal, reactive epoxide groups. A structurally
related compound, 1,6-hexanediol diglycidyl ether, has a reported EC3 value of 1.9% w/v,
classifying it as a strong sensitizer.25
Two monoaromatic compounds were also assessed in the KeratinoSensTM. Of these, epoxide
containing compound 3 was predicted to be a skin sensitizer (Imax = 120), while non-epoxide 4
was predicted as a non-sensitizer (Imax = 1.2). Neither 3 nor 4 were assessed in the LLNA, again
due to ethical considerations. On the basis of the results above, 3 would be expected to be a
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strong sensitizer in the LLNA due to the presence of the epoxide groups, analogous to PGE.21
Conversely, 4 is structurally related to 2 and would not be expected to act as a sensitizer due to
the lack of epoxide groups.
Reactivity Towards the Thiol Residue in Cysteine and in a Model Peptide
Small molecules react with reactive amino acid residues of proteins in the skin to form
immunogenic complexes, which are then recognized by the immune systems as ‘non-self’ and
provoke an immune response. Reactive amino acid residues that play a role in skin sensitization
include cysteines (thiol), lysines (amino) and to a lesser extent arginines, histidines, methionines
and tyrosines.45 It has been previously demonstrated that the epoxy reactive diluent PGE reacts
selectively with the thiol residue of a model peptide.23 We firstly investigated the reactivity of
DGEBF and compound 2 with a cysteine derivative (N-acetyl-L-cysteine methyl ester, NACME). LC/MS analysis of the DGEBF/N-ACME reaction after 24 hours showed the formation
of both monoadducts and diadducts, indicating that DGEBF is thiol-reactive. There was no
reaction between 2 and N-ACME, indicating that 2 is non-reactive towards free thiols. Further
reactions of compound 2 were not investigated, but we would predict that the methoxy group is
also unreactive towards other amino acids implicated in skin sensitization. The results of the
reactivity experiment with N-ACME indicate that the epoxide groups of DGEBF are necessary
for thiol binding.
Having confirmed that the epoxide group was required to react with cysteine, the reactivities of
DGEBF, compound 1 and PGE towards a model peptide were investigated. The three
compounds were chosen to investigate the relative reactivity of a biaromatic diepoxide, a
biaromatic monoepoxide and a monoaromatic monoepoxide. The hexapeptide chosen,
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AcPHCKRM, contains both cysteine and lysine amino acid residues. All compounds were stable
in the conditions of the assay.
The percentage peptide depletion was calculated for the three compounds (Figure 3 and Table
S3, Supporting Information). DGEBF and compound 1 are structurally similar with the only
difference being one terminal epoxide group in compound 1 compared to two in DGEBF. The
depletion is slightly faster for DGEBF compared to compound 1. The reactivity of DGEBF is
similar to that of PGE at 120 min (7.1% of free peptide remaining). To confirm the latter result, a
second experiment was performed in which both DGEBF and PGE were allowed to react
simultaneously with the peptide. 51.5% of DGEBF-peptide adduct was formed compared to
48.5% of PGE-peptide adduct, confirming that DGEBF and PGE react with this peptide in
essentially equimolar amounts.
Interestingly, the diepoxide DGEBF was observed to only form mono-adducts and did not crosslink peptides. This result is unexpected, as the ability to cross-link proteins could be a potential
reason for the enhanced response of DGEBF in the LLNA over compound 1. A potential reason
for the lack of cross-linking observed is that an excess of DGEBF compared to peptide is used in
this assay (10:1 ratio).
A cysteine adduct was observed for all three compounds, indicated by haptenated y5 and y4
fragments in the MS, but non-haptenated y3 and y2 fragments (Table 2 and Figure S1,
Supporting Information). No adducts with lysine or other residues were observed. This is in
agreement with previous results showing that the epoxides bind to cysteine residues in
peptides.23, 46
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In summary, the reactivity experiments indicate that both the biaromatic and monoaromatic
epoxide-containing compounds DGEBF, compound 1 and PGE can bind to thiol residues, while
compound 2 cannot. This explains the lack of sensitizing effects shown by 2 in the LLNA and
KeratinoSens™.
Cytotoxicity
All compounds were screened for in vitro cytotoxicity in the KeratinoSens™ cell line using the
MTT assay (Table 1).43 The IC50 values for the four biaromatic compounds DGEBA, DGEBF, 1
and 2 fall in the low micromolar range between 22 and 69 μM. Linear diepoxide 6 (IC50=169
μM) was over 7-fold less cytotoxic compared to both DGEBA and DGEBF. Compound 5 was
the least cytotoxic of the epoxide-containing compounds (IC50=284 μM). Cytotoxicity of
monoaromatic diepoxide 3 (IC50=38 μM) was in the same range as that of DGEBF, 1 and 2. The
monoepoxide PGE has an IC50 value of 182 μM while compound 4 did not reduce viability by
50% or more at concentrations up to 2,000 μM.
DGEBA is known both as an alkylating agent and as a PPARγ antagonist.32, 35 It is unknown at
present if DGEBA covalently modifies the PPARγ receptor.47 It is anticipated that DGEBF
causes cell death by similar mechanisms to DGEBA due to their structural similarity. The
relative loss in cytotoxic potency of the two linear epoxides 5 and 6 compared to DGEBF may
indicate that terminal epoxides are not the only structural feature required for potent cytotoxicity
in this cell line. DGEBF and compound 2 have equipotent cytotoxicity indicating that a
structurally similar compound without reactive epoxides may have a similar cytotoxicity in
monolayer cell culture. This is in contrast to the results observed for skin sensitization, where the
presence of epoxide groups was essential for sensitizing effects.
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The nature of the alkyl chain has a large impact on in vitro cytotoxicity when comparing
monoaromatic compounds PGE and 4. PGE is known to cause cell death via reactive
mechanisms, including DNA-damage,48 activation of heat shock response and antioxidant
response.49 PGE forms DNA-adducts via its epoxide group, causing cytotoxicity and apoptosis.
Compound 4 lacks the epoxide group, and therefore cannot bind to cellular thiols or cause cell
death by reactive mechanisms. Our results indicate that a reactive group is necessary for the
cytotoxic effect of the monoaromatic epoxides PGE and 3 in the cell line used in our study.
Conclusion
The aim of our work was to investigate the skin sensitizing potency and in vitro cytotoxicity of
analogues of the epoxy resin monomer DGEBF. These results have implications for the
development of new ERS components. We have shown that the skin sensitization potency of the
epoxy resin monomer DGEBF is due to its terminal epoxide groups. Based on our findings,
newly reported epoxy resin monomers50, 51 would be expected to cause skin sensitization and
allergic contact dermatitis as they contain terminal epoxide groups. Our results also imply that
there is a need for further research to try to decrease the reactivity of the epoxide groups to a
level where the contact sensitization is reduced but the polymerization capacity is still intact. We
have shown that the cytotoxicity of DGEBF in monolayer cell culture may not only be dependent
on the epoxide groups. Depending on the structure of alternative epoxy resins,50-52 reduced
cytotoxicity might be obtained. It is important to keep the potential adverse health effects of
epoxy resins in mind when developing a new system and to assess these effects at an early stage
in the development process.
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Tables
Table 1. Results from the KeratinoSens™ assaya
Luciferase Induction
Compound

ECKS1.5

Cytotoxicity
ECKS4.5

Imax Classification

a

IC50 (µM)
(µM)

(µM)

DGEBA21

13

Sensitizer

5.2

10

22

DGEBF21

5

Sensitizer

6.5

12

23

PGE21

56

Sensitizer

16

63

182

1

76

Sensitizer

5.7

19

69

2

2.2b Non-sensitizer

9.9b

No value

31

3

120

13

16

38

4

1.2

No value

> 2000

5

209

Sensitizer

60

105

284

6

43

Sensitizer

37

73

169

Sensitizer

Non-sensitizer No value

KeratinoSens™ assay performed using KeratinoSens™ reporter keratinocytes, which contain a stable insertion of a

luciferase gene under control of the ARE element of the AKR1C2 gene. Imax is defined as the average maximal
induction of gene activity. A luciferase induction of greater than 1.5-fold at non-cytotoxic concentrations was
considered to be significant for skin sensitization. All assays were performed in triplicate on at least 3 separate
occasions.
b

Fold-induction of > 1.5 was only noted at cytotoxic concentrations; therefore this compound is classified as a non-

sensitizer according to the KeratinoSens™
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Table 2. Ions and fragments observed in the reactivity experiment with peptide AcPHCKRMa

Hapten

a

Molecular
weight

[M* + H]+

[M* + 2H]2+

y5*

y4*

y3

y2

m/z

m/z

m/z

m/z

m/z

m/z

DGEBF

312.4

1125.4

563.3

986.4

849.3

434.2

306.2

1

314.4

1127.4

564.2

988.3

851.4

434.2

306.2

PGE

150.2

963.3

482.2

824.2

687.2

434.2

Ndb

M* or y* indicates haptenated peptide or peptide fragment, respectively; y indicates unhaptenated peptide

fragment. The mass of the unhaptenated peptide (M) is 813.2. The masses of the unhaptenated fragments are as
follows: y2: 306.2; y3: 434.2; y4: 537.3; y5: 674.3
b

Not detected.
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Figure Legends
Figure 1. Structures of DGEBA (diglycidyl ether of bisphenol A), DGEBF (diglycidyl ether of
bisphenol F), PGE (phenyl glycidyl ether) and analogues
Figure 2. Local Lymph Node Assay (LLNA) results for DGEBF, 1 and 2. The EC3 value (estimated
concentration required to induce a stimulation index (SI) of 3) was calculated using linear interpolation.
EC3 values are as follows: DGEBF: 0.036 M (1.1 % w/v);21 1: 0.074 M (2.3 % w/v); 2 > 0.95 M (> 30
% w/v).
Figure 3. Peptide depletion by DGEBF, 1 and PGE. The model peptide AcPHCKRM was incubated
with the relevant compound (1: 10) in a mixture of 1:1 DMSO: potassium phosphate buffer (100 mM,
pH 7.4). The reaction mixture was kept under argon at room temperature and was monitored by
UV/ESI-MS.
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Scheme Legends.
Scheme 1. Synthesis of compounds 1, 2 and 4a
*TBDMS=tert-butyldimethylsilyl
a

Reagents and conditions: A. (i) KOH, EtOH, N2, 24 h, reflux; (ii) 4-Methylmorpholine, THF, -20 ˚C (30 min), N2,

triethylamine, DMF, 0 ˚C (3.5 h); (iii) C4H9Li, THF, N2, -78 ˚C; (iv) ZnI2, NaBH3CN, ClCH2CH2Cl, 20 h, rt; (v)
TBAF, THF, N2, 3 h, rt; (vi) Cs2CO3, CH3CN, N2, 3 h, reflux. B & C. KOH, EtOH, N2, 4 h, reflux.

Scheme 2. Synthesis of compounds 5 and 6a
a

Reagents and conditions: (i) NaH, THF, N2, reflux, overnight; (ii) CHCl3, 0 ˚C then RT until complete on TLC
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Scheme 2.

40

